Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Numinus Wellness ( (TSE:NUMI) ) has issued an update.
Numinus Wellness Inc. has announced a cease trade order issued by the British Columbia Securities Commission due to the company’s failure to file its required financial statements on time. This delay is attributed to complexities arising from the sale of its U.S. wellness clinics. The Toronto Stock Exchange has suspended trading of the company’s securities. Despite this, Numinus continues its clinical trials and practitioner training and is working to resolve the regulatory issues to resume its growth strategy.
More about Numinus Wellness
Numinus Wellness Inc. is a mental healthcare company focused on advancing traditional and innovative behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. The company leads the integration of these therapies into mainstream clinical practice, offering technology-driven clinic support, clinical trial research, and comprehensive practitioner training.
YTD Price Performance: 25.00%
Average Trading Volume: 701,601
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$11.28M
For an in-depth examination of NUMI stock, go to TipRanks’ Stock Analysis page.
